1st Circ. Upholds Discovery Bid Nix In Gene-Editing IP Row
The First Circuit has affirmed a Massachusetts federal judge's decision to deny a patent agency's bid for discovery into an MIT lab's European patents for genome-editing technology, saying that the court...To view the full article, register now.
Already a subscriber? Click here to view full article